This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WAYNE F. LARRABEE, JR, MD
Seattle

Arch Otolaryngol Head Neck Surg. 1988;114(10):1102.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A series of papers presented at the 1988 spring meeting of the American Academy of Facial Plastic and Reconstructive Surgery in Palm Beach, Fla, addressed the problem of pharmacologic enhancement of skin flap survival in some interesting and innovative ways.

David B. Hom, MD, Shan R. Baker, MD, and Ken D. McClatchey, MD, Ann Arbor, Mich, treated island skin flaps in rabbits with angiogenic agents. There were 84 island skin flaps created on the auricles of New Zealand white rabbits. On day 3 postoperatively, the vascular pedicles were ligated to create partial flap necrosis. Thirty-six flaps were treated with endothelial growth supplement and endothelial cell–growth factor; the remainder were used as controls. The angiogenic agents were applied either topically or impregnated in Gelfoam placed under the flaps. In addition to a standard measurement of flap viability, the peripheral neovascularization was documented by angiograms and magnified with mammography techniques. The endothelial . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?